These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9138342)

  • 1. Enzyme polymorphism on the metabolic O-demethylation of dextromethorphan in a South American population.
    Estévez F; Giusti M; Parrillo S; Oxandabarat J
    Medicina (B Aires); 1996; 56(4):378-82. PubMed ID: 9138342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dextromethorphan O-demethylation and dextrorphan glucuronidation in a French population.
    Duché JC; Quérol-Ferrer V; Barré J; Mésangeau M; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):392-8. PubMed ID: 8225685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism of dextromethorphan oxidation in Polish population.
    Skretkowicz J; Wojtczak A; Rychlik-Sych M
    Acta Pol Pharm; 2008; 65(5):611-5. PubMed ID: 19051610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of dextromethorphan oxidation in South Indian subjects.
    Mamidi RN; Satyavageeswaran S; Vakkalanka SV; Chaluvadi MR; Katneni K; Brahmadevara N; Damodarram G; Subramaniam S
    Clin Pharmacol Ther; 1999 Aug; 66(2):193-200. PubMed ID: 10460073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dextromethorphan O-demethylation polymorphism in Jordanians.
    Irshaid YM; al-Hadidi HF; Rawashdeh NM
    Eur J Clin Pharmacol; 1993; 45(3):271-3. PubMed ID: 8276053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC-MS/MS analysis of dextromethorphan metabolism in human saliva and urine to determine CYP2D6 phenotype and individual variability in N-demethylation and glucuronidation.
    Lutz U; Völkel W; Lutz RW; Lutz WK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):217-25. PubMed ID: 15556536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid thin layer chromatographic procedure to identify poor and extensive oxidative drug metabolizers in man using dextromethorphan.
    De Zeeuw RA; Eikema D; Franke JP; Jonkman JH
    Pharmazie; 1992 May; 47(5):346-8. PubMed ID: 1409826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative phenotype status in related subjects.
    Rychlik-Sych M; Łyczba M; Skretkowicz J
    Acta Pol Pharm; 2008; 65(1):165-8. PubMed ID: 18536192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency distribution of dextromethorphan O-demethylation in a Greek population.
    Kimiskidis VK; Niopas I; Firinidis PD; Kanaze FI; Gabrieli C; Kazis D; Papagiannopoulos S; Kazis A
    Int J Clin Pharmacol Ther; 2005 Mar; 43(3):150-3. PubMed ID: 15792399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphic formation of morphine from codeine in poor and extensive metabolizers of dextromethorphan: relationship to the presence of immunoidentified cytochrome P-450IID1.
    Mortimer O; Persson K; Ladona MG; Spalding D; Zanger UM; Meyer UA; Rane A
    Clin Pharmacol Ther; 1990 Jan; 47(1):27-35. PubMed ID: 2295216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dextromethorphan O-demethylation in a large number of French Caucasian families.
    Vincent-Viry M; Fournier B; Siest G; Galteau MM
    Pharmacogenetics; 1992 Jun; 2(3):135-8. PubMed ID: 1306113
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of CYP2D6 in pregnancy.
    Wadelius M; Darj E; Frenne G; Rane A
    Clin Pharmacol Ther; 1997 Oct; 62(4):400-7. PubMed ID: 9357391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphism of CYP2D6 in Karnataka and Andhra Pradesh population in India.
    Abraham BK; Adithan C; Kiran PU; Asad M; Koumaravelou K
    Acta Pharmacol Sin; 2000 Jun; 21(6):494-8. PubMed ID: 11360682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of dextromethorphan O-demethylation in man.
    Küpfer A; Schmid B; Pfaff G
    Xenobiotica; 1986 May; 16(5):421-33. PubMed ID: 3739367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dextromethorphan metabolism in Jordanians: dissociation of dextromethorphan O-demethylation from debrisoquine 4-hydroxylation.
    Irshaid YM; al-Hadidi HF; Latif A; Awwadi F; al-Zoubi M; Rawashdeh NM
    Eur J Drug Metab Pharmacokinet; 1996; 21(4):301-7. PubMed ID: 9074894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers.
    Pope LE; Khalil MH; Berg JE; Stiles M; Yakatan GJ; Sellers EM
    J Clin Pharmacol; 2004 Oct; 44(10):1132-42. PubMed ID: 15342614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low frequency of dextromethorphan O-demethylation deficiency in a Chinese population.
    Lane HY; Deng HC; Huang SM; Hu WH; Chang WH; Hu OY
    Clin Pharmacol Ther; 1996 Dec; 60(6):696-8. PubMed ID: 8988073
    [No Abstract]   [Full Text] [Related]  

  • 18. Dextromethorphan O-demethylation polymorphism in the Uruguayan population.
    Estevez F; Giusti M; Parrillo S; Oxandabarat J
    Eur J Clin Pharmacol; 1997; 52(5):417-8. PubMed ID: 9272415
    [No Abstract]   [Full Text] [Related]  

  • 19. Polymorphic O-demethylation of codeine.
    Chen ZR; Somogyi AA; Bochner F
    Lancet; 1988 Oct; 2(8616):914-5. PubMed ID: 2902373
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population.
    Griese EU; Asante-Poku S; Ofori-Adjei D; Mikus G; Eichelbaum M
    Pharmacogenetics; 1999 Dec; 9(6):715-23. PubMed ID: 10634134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.